Bixiye
QP4-17 APR-DRG and EAPG Grouper Discrepancy Identified
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3151 - 3160 ee natiijooyinka 3273
Bixiye
QP3-17 Interpreter Services - Correct Unit of Service Billing
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2017
Bixiye
QP2-17 Post Hospitalization Additional Benefits for SecureBlue Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2017
Bixiye
P6-17 A New Drug, Emflaza (deflazacort), Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2017
Bixiye
2017 March Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: 16, Feb 2017
Bixiye
P5-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2017
Bixiye
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 30, 2017
Bixiye
P2-17 Updated: Change in Coverage for Detoxification Services for Minnesota Health Care Programs Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2017
Bixiye
P3-17 Added Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2017
Bixiye
P1-17 Prior Authorization Requirement for Gender Dysphoria
Taariikhda uu dhaqangalayo Barnaamijka: Jan 18, 2017